Patients with normal potassium and creatinine
levels at admission benefitted from a maintenance intravenous
dose of potassium of 72 to 144 mmol/L per day. Compared with
control patients, patients receiving this dose avoided detrimental
hypokalemic events, had fewer invasive procedures and lower
costs, and required less nursing care.